Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
See Omnibus Budget Reconciliation Act of 1990 (OBRA '90) Basic Framework of OBRA ‘90 Components of Prospective Drug Use Review Federal Regulation of Pharmacy Practice Preface Rationale for Expanded Pharmacist Duties See Omnibus Budget Reconciliation Act of 1990 (OBRA '90) The Omnibus Budget Reconciliation Act of 1990
Occupational Safety and Health Act
Occupational Safety and Health Administration (OCSHA)
See Office for Civil Rights (OCR) Health Information Technology Infrastructure Health Insurance Portability and Accountability Act of 1996 Penalties and Enforcement See Office for Civil Rights (OCR) Use and Disclosure of PHI; Right to Access
Odell v. Axelrod (1984)
Office for Civil Rights (OCR)
Office of Inspector General (OIG)
Office of Prescription Drug Promotion
Office of the National Coordinator for HIT (ONCHIT)
off-label (unlabeled) indications, approved drugs for
off-label use of medication advertising and promotion Heckler V. Chaney (1984) - Heckler V. Chaney Ramon V. Farr (1989) - Ramon V. Farr
See Office of Inspector General (OIG) 340B Drugs Actions Against a License Anti-Kickback Statute Medicare Part D Overview of Important Developments in Medicaid and Prescription Drug Reimbursement Prescription Drug Advertising: Manufacturer to Professionals See Office of Inspector General (OIG)
OIG Compliance Program Guidance for Pharmaceutical Manufacturers
Omnibus Budget Reconciliation Act of 1990 (OBRA '90)
Omnibus Budget Reconciliation Act of 1990 (OBRA ‘90) drug utilization review (DUR) off-label uses of medications overview standards of practice State Regulation of Third-Party Plans The Omnibus Budget Reconciliation Act of 1990
online pharmacies
opiate dependence
opinion, defined
opioid products addiction treatment programs prescriptions validity
opioid treatment programs (OTPs) methadone Opioid Treatment Programs Purpose of a Controlled Substance Prescription treatment of addicts
oral prescriptions, dispensing of
Orange Book
ordinances, overview
Oregon Board of Pharmacy
Orphan Drug Act (1983)
orphan drugs Reasons to Regulate Medicinal Drugs The Patient Safety and Quality Improvement Act of 2005
orthotics
See over-the-counter (OTC) drugs Federal Regulation of Medications: Development, Production, and Marketing See over-the-counter (OTC) drugs Use and Disclosure of PHI; Right to Access
See opioid treatment programs (OTPs) Issuance of Prescriptions Methadone Opioid Treatment Programs Preface Purpose of a Controlled Substance Prescription See opioid treatment programs (OTPs) The Closed System of Controlled Substance Distribution Treatment of Addicts Outside of OTPs
outcomes, regulations for